“Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2”. Nat. Genet.23 (2): 185–8. (October 1999). doi:10.1038/13810. PMID10508514.
“Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA”. Cell69 (6): 905–14. (June 1992). doi:10.1016/0092-8674(92)90610-O. PMID1606614.
“Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation”. J. Biol. Chem.278 (34): 32181–8. (August 2003). doi:10.1074/jbc.M305308200. PMID12788925.
“The solution structure of the domain from MeCP2 that binds to methylated DNA”. J. Mol. Biol.291 (5): 1055–65. (September 1999). doi:10.1006/jmbi.1999.3023. PMID10518942.
“MeCP2 in neurons: closing in on the causes of Rett syndrome”. Hum. Mol. Genet.14 Spec No 1: R19–26. (April 2005). doi:10.1093/hmg/ddi102. PMID15809268.
“Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders”. Hum. Mol. Genet.13 (6): 629–39. (March 2004). doi:10.1093/hmg/ddh063. PMID14734626.
“The Ski protein family is required for MeCP2-mediated transcriptional repression”. J. Biol. Chem.276 (36): 34115–21. (September 2001). doi:10.1074/jbc.M105747200. PMID11441023.
“Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA”. Nat. Neurosci.10 (12): 1513–4. (December 2007). doi:10.1038/nn2010. PMID17994015.
“Sex difference in mecp2 expression during a critical period of rat brain development”. Epigenetics2 (3): 173–8. (September 2007). doi:10.4161/epi.2.3.4841. PMID17965589.
“Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice”. Neuropsychopharmacology29 (3): 483–93. (March 2004). doi:10.1038/sj.npp.1300360. PMID14647484.
“Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2”. Nat. Genet.23 (2): 185–8. (October 1999). doi:10.1038/13810. PMID10508514.
“Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA”. Cell69 (6): 905–14. (June 1992). doi:10.1016/0092-8674(92)90610-O. PMID1606614.
“Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation”. J. Biol. Chem.278 (34): 32181–8. (August 2003). doi:10.1074/jbc.M305308200. PMID12788925.
“The solution structure of the domain from MeCP2 that binds to methylated DNA”. J. Mol. Biol.291 (5): 1055–65. (September 1999). doi:10.1006/jmbi.1999.3023. PMID10518942.
“MeCP2 in neurons: closing in on the causes of Rett syndrome”. Hum. Mol. Genet.14 Spec No 1: R19–26. (April 2005). doi:10.1093/hmg/ddi102. PMID15809268.
“Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders”. Hum. Mol. Genet.13 (6): 629–39. (March 2004). doi:10.1093/hmg/ddh063. PMID14734626.
“The Ski protein family is required for MeCP2-mediated transcriptional repression”. J. Biol. Chem.276 (36): 34115–21. (September 2001). doi:10.1074/jbc.M105747200. PMID11441023.
“Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA”. Nat. Neurosci.10 (12): 1513–4. (December 2007). doi:10.1038/nn2010. PMID17994015.
“Sex difference in mecp2 expression during a critical period of rat brain development”. Epigenetics2 (3): 173–8. (September 2007). doi:10.4161/epi.2.3.4841. PMID17965589.
“Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice”. Neuropsychopharmacology29 (3): 483–93. (March 2004). doi:10.1038/sj.npp.1300360. PMID14647484.